Corporate Member Update: Boehringer Ingelheim, Inc.- COSELA™ (trilaciclib)
Corporate Member Update: Boehringer Ingelheim, Inc.- COSELA™ (trilaciclib)
COSELA™ (trilaciclib)
September, 2021
G1 Therapeutics, Inc. secures permanent J Code for COSELA™ (trilaciclib). The code, J1448, is effective on October 1, 2021. Visit COSELA.com for more information.
